drugset / Trial / NCT00598130

Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy

NCT00598130 ↗

Phase 2 Completed 30 enrolled OMRIX Biopharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, randomized, single blind, standard care- controlled study, which will include a total of 30 patients divided into two treatment arms: First are: patents who will be treated in accordance with standard of care. Second arm: patients for which the Fibrin Fleece will be applied directly on the active bleeding site.

Timeline

Start
2008-02
Primary completion
2008-11
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fleece Unknown — —

Indications

No indication recorded.